Our mission is to improve the quality of human life by enabling people to do more, feel better, live longer. Discover more about us below...
We are the 1st pharmaceutical company to sign up to the AllTrials campaign for research transparency.
We invested £3.4 billion in 2013 in our search to develop new medicines, vaccines and consumer products.
Six major new products approved in 2013 (in areas including respiratory disease, HIV and cancer).
We have 40 new molecular entities in phase II/III development.
We have 86 manufacturing sites in 36 countries make our medicines, vaccines and consumer healthcare products.
4 billion albendazole tablets donated to eliminate two neglected tropical diseases since 1998.
In 2009 we launched ViiV Healthcare with Pfizer to deliver advances in treatment and care for people living in HIV.
More than 12,500 people work in R&D in our search for new medicines, vaccines and consumer healthcare products.
860 million vaccine doses were distributed to 170 countries in 2013, 80% of which were to developing countries.
We employ more than 99,000 people in over 100 countries, with more than a third of these in emerging markets.
We have had a 60% increase in the volume of medicines supplied to LDC since 2010.
£26.5bn group turnover in 2013 up 1% CER.